CLSI M29 A3 : 3ED 2005
Superseded
Superseded
A superseded Standard is one, which is fully replaced by another Standard, which is a new edition of the same Standard.
View Superseded by
ACQUIRED INFECTIONS; APPROVED GUIDELINE
Superseded date
01-05-2014
Superseded by
Published date
12-01-2013
Publisher
Sorry this product is not available in your region.
Describes the risk of transmission of infectious agents by aersols, droplets, blood and body substances in a laboratory setting; specific precautions for preventing the laboratory transmission of microbial infection from laboratory instruments and materials; and recommendations for the management of exposure to infectious agents.
| DevelopmentNote |
Supersedes NCCLS M29 A2. (03/2005)
|
| DocumentType |
Miscellaneous Product
|
| PublisherName |
Clinical Laboratory Standards Institute
|
| Status |
Superseded
|
| SupersededBy | |
| Supersedes |
| CLSI I/LA29 A : 1ED 2008 | DETECTION OF HLA-SPECIFIC ALLOANTIBODY BY FLOW CYTOMETRY AND SOLID PHASE ASSAYS |
| CLSI POCT10 A2 : 2ED 2011 | PHYSICIAN AND NONPHYSICIAN PROVIDER-PERFORMED MICROSCOPY TESTING |
| CLSI M43 A : 1ED 2011 | METHODS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING FOR HUMAN MYCOPLASMAS |
| CLSI M54 A : 2012 | PRINCIPLES AND PROCEDURES FOR DETECTION OF FUNGI IN CLINICAL SPECIMENS - DIRECT EXAMINATION AND CULTURE |
| CLSI NBS02 A2 : 2ED 2013 | NEWBORN SCREENING FOLLOW-UP |
| CLSI AUTO3 A2 : 2ED 2009 | LABORATORY AUTOMATION: COMMUNICATIONS WITH AUTOMATED CLINICAL LABORATORY SYSTEMS, INSTRUMENTS, DEVICES, AND INFORMATION SYSTEMS |
| CLSI MM7 A2 : 2ED 2013 | FLUORESCENCE IN SITU HYBRIDIZATION METHODS FOR CLINICAL LABORATORIES |
| CLSI EP18 A2 : 2ED 2009 | RISK MANAGEMENT TECHNIQUES TO IDENTIFY AND CONTROL LABORATORY ERROR SOURCES |
| CLSI POCT11 A2 : 2ED 2011 | PULSE OXIMETRY |
| CLSI H42 A2 : 2ED 2007 | ENUMERATION OF IMMUNOLOGICALLY DEFINED CELL POPULATIONS BY FLOW CYTOMETRY |
| CLSI MM9 A2 : 2ED 2014 | NUCLEIC ACID SEQUENCING METHODS IN DIAGNOSTIC LABORATORY MEDICINE |
| CLSI M38 A2 : 2ED 2008 | REFERENCE METHOD FOR BROTH DILUTION ANTIFUNGAL SUSCEPTIBILITY TESTING OF FILAMENTOUS FUNGI |
| CLSI EP25 A : 1ED 2009 | EVALUATION OF STABILITY OF IN VITRO DIAGNOSTIC REAGENTS |
| CLSI EP26 A : 1ED 2013 | USER EVALUATION OF BETWEEN-REAGENT LOT VARIATION |
| CLSI H54 A : 1ED 2005 | PROCEDURES FOR VALIDATION OF INR AND LOCAL CALIBRATION OF PT/INR SYSTEMS |
| CLSI C52 A2 : 2ED 2007 | TOXICOLOGY AND DRUG TESTING IN THE CLINICAL LABORATORY |
| CLSI EP22 P : 1ED 2010 | PRESENTATION OF A MANUFACTURER'S RISK MITIGATION INFORMATION FOR USERS OF IN VITRO DIAGNOSTIC DEVICES |
| CLSI M11 A7 : 7ED 2007 | METHODS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING OF ANAEROBIC BACTERIA |
| CLSI H43 A2 : 2ED 2007 | CLINICAL FLOW CYTOMETRIC ANALYSIS OF NEOPLASTIC HEMATOLYMPHOID CELLS |
| CLSI MM18 A : 1ED 2008 | INTERPRETIVE CRITERIA FOR IDENTIFICATION OF BACTERIA AND FUNGI BY DNA TARGET SEQUENCING |
| CLSI C58 A : 1ED 2011 | ASSESSMENT OF FETAL LUNG MATURITY BY THE LAMELLAR BODY COUNT |
| CLSI H45 A2 : 2ED 2005 | PERFORMANCE OF THE BLEEDING TIME TEST |
| CLSI M45 A2 : 2ED 2010 | METHODS FOR ANTIMICROBIAL DILUTION AND DISK SUSCEPTIBILITY TESTING OF INFREQUENTLY ISOLATED OR FASTIDIOUS BACTERIA |
| BIS IS/ISO 15189 : 2012 | MEDICAL LABORATORIES - REQUIREMENTS FOR QUALITY AND COMPETENCE |
| CLSI EP27 A : 1ED 2012 | HOW TO CONSTRUCT AND INTERPRET AN ERROR GRID FOR QUANTITATIVE DIAGNOSTIC ASSAYS |
| CLSI POCT4 A2 : 2ED 2006 | POINT-OF-CARE IN VITRO DIAGNOSTIC (IVD) TESTING |
| CLSI GP5 A3 : 3ED 2011 | CLINICAL LABORATORY WASTE MANAGEMENT |
| CLSI H60 A : 1ED 2014 | LABORATORY TESTING FOR THE LUPUS ANTICOAGULANT |
| I.S. EN ISO 15189:2012 | MEDICAL LABORATORIES - REQUIREMENTS FOR QUALITY AND COMPETENCE (ISO 15189:2012, CORRECTED VERSION 2014-08-15) |
| CLSI NBS06 A : 1ED 2013 | NEWBORN BLOOD SPOT SCREENING FOR SEVERE COMBINED IMMUNODEFICIENCY BY MEASUREMENT OF T-CELL RECEPTOR EXCISION CIRCLES |
| CLSI POCT9 A : 1ED 2010 | SELECTION CRITERIA FOR POINT-OF-CARE TESTING DEVICES |
| CLSI MM1 A3 : 3ED 2012 | MOLECULAR METHODS FOR CLINICAL GENETICS AND ONCOLOGY TESTING |
| CLSI EP12 A2 : 2ED 2008 | USER PROTOCOL FOR EVALUATION OF QUALITATIVE TEST PERFORMANCE |
| CLSI M35 A2 : 2ED 2008 | ABBREVIATED IDENTIFICATION OF BACTERIA AND YEAST |
| CLSI NBS01 A6 : 6ED 2013 | BLOOD COLLECTION ON FILTER PAPER FOR NEWBORN SCREENING PROGRAMS |
| CLSI H21 A5 : 5ED 2008 | COLLECTION, TRANSPORT, AND PROCESSING OF BLOOD SPECIMENS FOR TESTING PLASMA-BASED COAGULATION ASSAYS AND MOLECULAR HEMOSTASIS ASSAYS |
| CLSI M11 A8 : 8ED 2012 | METHODS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING OF ANAEROBIC BACTERIA |
| CLSI I/LA28 A2 : 2ED 2011 | QUALITY ASSURANCE FOR DESIGN CONTROL AND IMPLEMENTATION OF IMMUNOHISTOCHEMISTRY ASSAYS |
| CLSI MM17 P : 1ED 2007 | VERIFICATION AND VALIDATION OF MULTIPLEX NUCLEIC ACID ASSAYS |
| CLSI NBS03 A : 1ED 2009 | NEWBORN SCREENING FOR PRETERM, LOW BIRTH WEIGHT, AND SICK NEWBORNS |
| CLSI C56 A : 1ED 2012 | HEMOLYSIS, ICTERUS, AND LIPEMIA/TURBIDITY INDICES AS INDICATORS OF INTERFERENCE IN CLINICAL LABORATORY ANALYSIS |
| CLSI MM13 A : 1ED 2006 | COLLECTION, TRANSPORT, PREPARATION, AND STORAGE OF SPECIMENS FOR MOLECULAR METHODS |
| CLSI I/LA2 A2 : 2ED 2006 | QUALITY ASSURANCE OF LABORATORY TESTS FOR AUTOANTIBODIES TO NUCLEAR ANTIGENS: (1) INDIRECT FLUORESCENCE ASSAY FOR MICROSCOPY AND (2) MICROTITER ENZYME IMMUNOASSAY METHODS |
| CLSI M44 A2 : 2ED 2009 | METHOD FOR ANTIFUNGAL DISK DIFFUSION SUSCEPTIBILITY TESTING OF YEASTS<br> |
| CLSI GP15 A3 : 3ED 2008 | CERVICOVAGINAL CYTOLOGY BASED ON THE PAPANICOLAOU TECHNIQUE |
| CLSI EP27 P : 1ED 2009 | HOW TO CONSTRUCT AND INTERPRET AN ERROR GRID FOR DIAGNOSTIC ASSAYS |
| CLSI POCT7 A : 1ED 2010 | QUALITY MANAGEMENT: APPROACHES TO REDUCING ERRORS AT THE POINT OF CARE |
| CLSI POCT8 A : 1ED 2010 | QUALITY PRACTICES IN NONINSTRUMENTED POINT-OF-CARE TESTING: AN INSTRUCTIONAL MANUAL AND RESOURCES FOR HEALTH CARE WORKERS |
| CLSI MM10 A : 1ED 2006 | GENOTYPING FOR INFECTIOUS DISEASES: IDENTIFICATION AND CHARACTERIZATION |
| CLSI EP17 A2 : 2ED 2012 | EVALUATION OF DETECTION CAPABILITY FOR CLINICAL LABORATORY MEASUREMENT PROCEDURES |
| PREN ISO 15189 : DRAFT 2011 | MEDICAL LABORATORIES - PARTICULAR REQUIREMENTS FOR QUALITY AND COMPETENCE |
| UNE-EN ISO 15189:2013 | Medical laboratories - Requirements for quality and competence (ISO 15189:2012, Corrected version 2014-08-15) |
| CLSI AUTO2 A2 : 2ED 2005 | LABORATORY AUTOMATION: BAR CODES FOR SPECIMEN CONTAINER IDENTIFICATION |
| CLSI M48 A : 1ED 2008 | LABORATORY DETECTION AND IDENTIFICATION OF MYCOBACTERIA |
| CLSI GP34 P : 1ED 2009 | VALIDATION AND VERIFICATION OF TUBES FOR VENOUS AND CAPILLARY BLOOD SPECIMEN COLLECTION |
| CLSI POCT7 P : 1ED 2009 | QUALITY MANAGEMENT: APPROACHES TO REDUCING ERRORS AT THE POINT OF CARE |
| CLSI MM5 A2 : 2ED 2012 | NUCLEIC ACID AMPLIFICATION ASSAYS FOR MOLECULAR HEMATOPATHOLOGY |
| CLSI EP23 A : 1ED 2011 | LABORATORY QUALITY CONTROL BASED ON RISK MANAGEMENT |
| CLSI GP2 A5 : 5ED 2006 | LABORATORY DOCUMENTS - DEVELOPMENT AND CONTROL |
| CLSI M41 A : 1ED 2006 | VIRAL CULTURE |
| CLSI POCT9 P : 1ED 2009 | SELECTION CRITERIA FOR POINT-OF-CARE TESTING DEVICES |
| CLSI MM13 P : 1ED 2005 | COLLECTION, TRANSPORT, PREPARATION, AND STORAGE OF SPECIMENS FOR MOLECULAR METHODS |
| CLSI EP30 A : 1ED 2010 | CHARACTERIZATION AND QUALIFICATION OF COMMUTABLE REFERENCE MATERIALS FOR LABORATORY MEDICINE |
| CLSI I/LA34 P : 1ED 2010 | DESIGN AND VALIDATION OF IMMUNOASSAYS FOR ASSESSMENT OF HUMAN ALLERGENICITY OF NEW BIOTHERAPEUTIC DRUGS |
| CLSI MM6 A2 : 2ED 2010 | QUANTITATIVE MOLECULAR METHODS FOR INFECTIOUS DISEASES |
| CLSI M2 A10 : 10ED 2008 | PERFORMANCE STANDARDS FOR ANTIMICROBIAL DISK SUSCEPTIBILITY TESTS |
| CLSI M7 A7 : 7ED 2006 | METHODS FOR DILUTION ANTIMICROBIAL SUSCEPTIBILITY TESTS FOR BACTERIA THAT GROW AEROBICALLY |
| CLSI NBS04 A : 1ED 2010 | NEWBORN SCREENING BY TANDEM MASS SPECTROMETRY<br> |
| CLSI C34 A3 : 3ED 2009 | SWEAT TESTING: SAMPLE COLLECTION AND QUANTITATIVE CHLORIDE ANALYSIS |
| CLSI NBS01 A5 : 5ED 2007 | BLOOD COLLECTION ON FILTER PAPER FOR NEWBORN SCREENING PROGRAMS |
| CLSI GP44 A4 : 4ED 2010 | PROCEDURES FOR THE HANDLING AND PROCESSING OF BLOOD SPECIMENS FOR COMMON LABORATORY TESTS |
| CLSI MM17 A : 1ED 2008 | VERIFICATION AND VALIDATION OF MULTIPLEX NUCLEIC ACID ASSAYS |
| CLSI H52 A2 : 2ED 2014 | Red Blood Cell Diagnostic Testing Using Flow Cytometry; Approved Guideline—Second Edition |
| CLSI VET01 A4 : 4ED 2013 | PERFORMANCE STANDARDS FOR ANTIMICROBIAL DISK AND DILUTION SUSCEPTIBILITY TESTS FOR BACTERIA ISOLATED FROM ANIMALS |
| DIN EN ISO 15189:2014-11 | Medical laboratories - Requirements for quality and competence (ISO 15189:2012, Corrected version 2014-08-15) |
| UNI EN ISO 15189 : 2013 | MEDICAL LABORATORIES - REQUIREMENTS FOR QUALITY AND COMPETENCE |
| CLSI H20 A2 : 2ED 2007 | Reference Leukocyte (WBC) Differential Count (Proportional) and Evaluation of Instrumental Methods, 2nd Edition<br> |
| CLSI GP16-A3 : 2009 | Urinalysis; Approved Guideline—Third Edition |
| CLSI M39 A4 : 4ED 2014 | ANALYSIS AND PRESENTATION OF CUMULATIVE ANTIMICROBIAL SUSCEPTIBILITY TEST DATA |
| CLSI I/LA34 A : 1ED 2011 | DESIGN AND VALIDATION OF IMMUNOASSAYS FOR ASSESSMENT OF HUMAN ALLERGENICITY OF NEW BIOTHERAPEUTIC DRUGS |
| CLSI EP31 A : 1ED 2008 | VERIFICATION OF COMPARABILITY OF PATIENT RESULTS WITHIN ONE HEALTH CARE SYSTEM |
| CLSI NBS05 A : 1ED 2011 | NEWBORN SCREENING FOR CYSTIC FIBROSIS |
| CLSI C24 A3 : 3ED 2006 | STATISTICAL QUALITY CONTROL FOR QUANTITATIVE MEASUREMENT PROCEDURES: PRINCIPLES AND DEFINITIONS |
| CLSI EP24 A2 : 2ED 2011 | ASSESSMENT OF THE DIAGNOSTIC ACCURACY OF LABORATORY TESTS USING RECEIVER OPERATING CHARACTERISTIC CURVES |
| CLSI M7 A8 : 8ED 2008 | METHODS FOR DILUTION ANTIMICROBIAL SUSCEPTIBILITY TESTS FOR BACTERIA THAT GROW AEROBICALLY |
| CLSI H59 P : 1ED 2010 | QUANTITATIVE D-DIMER FOR THE EXCLUSION OF VENOUS THROMBOEMBOLIC DISEASE |
| CLSI QMS04 A2 : 2ED 2007 | LABORATORY DESIGN |
| CLSI H26 A2 : 2ED 2010 | VALIDATION, VERIFICATION, AND QUALITY ASSURANCE OF AUTOMATED HEMATOLOGY ANALYZERS |
| CLSI I/LA30 P : 1ED 2007 | IMMUNOASSAY INTERFERENCE BY ENDOGENOUS ANTIBODIES |
| CLSI MM10 P : 1ED 2005 | GENOTYPING FOR INFECTIOUS DISEASES: IDENTIFICATION AND CHARACTERIZATION |
| CLSI I/LA21 A2 : 2ED 2008 | CLINICAL EVALUATION OF IMMUNOASSAYS |
| CLSI MM18 P : 1ED 2007 | INTERPRETIVE CRITERIA FOR MICROORGANISM IDENTIFICATION BY DNA TARGET SEQUENCING<br> |
| CLSI MM1 A2 : 2ED 2006 | MOLECULAR DIAGNOSTIC METHODS FOR GENETIC DISEASES |
| CLSI MM22 A : 1ED 2014 | MICROARRAYS FOR DIAGNOSIS AND MONITORING OF INFECTIOUS DISEASES |
| CLSI H47 A2 : 2ED 2008 | ONE-STAGE PROTHROMBIN TIME (PT) TEST AND ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) TEST |
| CLSI I/LA31 P : 1ED 2008 | NEWBORN SCREENING GUIDELINES FOR PREMATURE AND/OR SICK NEWBORNS<br> |
| CLSI M27 S3 : 3ED 2008 | REFERENCE METHOD FOR BROTH DILUTION ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEASTS |
| CLSI I/LA32 P : 1ED 2009 | NEWBORN SCREENING BY TANDEM MASS SPECTROMETRY |
| CLSI MM20 A : 1ED 2012 | QUALITY MANAGEMENT FOR MOLECULAR GENETIC TESTING |
| CLSI MM11 A : 1ED 2007 | MOLECULAR METHODS FOR BACTERIAL STRAIN TYPING |
| CLSI POCT5 P : 1ED 2008 | PERFORMANCE METRICS FOR CONTINUOUS INTERSTITIAL GLUCOSE MONITORING |
| CLSI MM11 P : 1ED 2006 | MOLECULAR METHODS FOR BACTERIAL STRAIN TYPING |
| CLSI I/LA33 A : 1ED 2009 | VALIDATION OF AUTOMATED SYSTEMS FOR IMMUNOHEMATOLOGICAL TESTING BEFORE IMPLEMENTATION |
| 11/30173018 DC : 0 | BS EN ISO 15189 - MEDICAL LABORATORIES - PARTICULAR REQUIREMENTS FOR QUALITY AND COMPETENCE |
| CLSI C53 P : 1ED 2008 | CHARACTERIZATION AND QUALIFICATION OF COMMUTABLE REFERENCE MATERIALS FOR LABORATORY MEDICINE |
| CLSI H58 AE : 1ED 2008 | PLATELET FUNCTION TESTING BY AGGREGOMETRY |
| CLSI EP28 A3 : 3ED 2010 | DEFINING, ESTABLISHING, AND VERIFYING REFERENCE INTERVALS IN THE CLINICAL LABORATORY |
| CLSI MM19 A : 1ED 2011 | ESTABLISHING MOLECULAR TESTING IN CLINICAL LABORATORY ENVIRONMENTS |
| CLSI I/LA25 A2 : 2011 | MATERNAL SERUM SCREENING |
| ISO 15189:2012 | Medical laboratories — Requirements for quality and competence |
| BS EN ISO 15189:2012 | Medical laboratories. Requirements for quality and competence |
| CLSI QMS01 A4 : 4ED 2011 | QUALITY MANAGEMENT SYSTEM: A MODEL FOR LABORATORY SERVICES |
| CLSI POCT13 A2 : 2ED 2005 | GLUCOSE MONITORING IN SETTINGS WITHOUT LABORATORY SUPPORT |
| CLSI I/LA20 A2 : 2ED 2009 | ANALYTICAL PERFORMANCE CHARACTERISTICS AND CLINICAL UTILITY OF IMMUNOLOGICAL ASSAYS FOR HUMAN IMMUNOGLOBULIN E (IGE) ANTIBODIES AND DEFINED ALLERGEN SPECIFICITIES |
| CLSI EP18 P2 : 2ED 2007 | RISK MANAGEMENT TECHNIQUES TO IDENTIFY AND CONTROL LABORATORY ERROR SOURCES |
| CLSI M28 A2 : 2ED 2005 | PROCEDURES FOR THE RECOVERY AND IDENTIFICATION OF PARASITES FROM THE INTESTINAL TRACT |
| CLSI I/LA30 A : 1ED 2008 | IMMUNOASSAY INTERFERENCE BY ENDOGENOUS ANTIBODIES |
| CLSI GP39 A6 : 6ED 2010 | TUBES AND ADDITIVES FOR VENOUS AND CAPILLARY BLOOD SPECIMEN COLLECTION |
| CLSI GP34 A : 1ED 2010 | VALIDATION AND VERIFICATION OF TUBES FOR VENOUS AND CAPILLARY BLOOD SPECIMEN COLLECTION |
| CLSI M41 P : 1ED 2006 | VIRAL CULTURE |
| CLSI POCT5 A : 1ED 2008 | PERFORMANCE METRICS FOR CONTINUOUS INTERSTITIAL GLUCOSE MONITORING |
| CLSI H59 A : 1ED 2011 | QUANTITATIVE D-DIMER FOR THE EXCLUSION OF VENOUS THROMBOEMBOLIC DISEASE |
| CLSI MM19 P : 1ED 2011 | ESTABLISHING MOLECULAR TESTING IN CLINICAL LABORATORY ENVIRONMENTS |
| CLSI M47 A : 1ED 2007 | PRINCIPLES AND PROCEDURES FOR BLOOD CULTURES |
| CLSI VET05 R : 1ED 2011 | GENERATION, PRESENTATION, AND APPLICATION OF ANTIMICROBIAL SUSCEPTIBILITY TEST DATA FOR BACTERIA OF ANIMAL ORIGIN |
| CLSI C49 A : 1ED 2007 | ANALYSIS OF BODY FLUIDS IN CLINICAL CHEMISTRY |
| CLSI C40 A2 : 2ED 2013 | MEASUREMENT PROCEDURES FOR THE DETERMINATION OF LEAD CONCENTRATIONS IN BLOOD AND URINE |
| CLSI M27 A3 : 3ED 2008 | REFERENCE METHOD FOR BROTH DILUTION ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEASTS |
| CLSI GP41 A6 : 6ED 2007 | PROCEDURES FOR THE COLLECTION OF DIAGNOSTIC BLOOD SPECIMENS BY VENIPUNCTURE |
| CLSI M53 A : 1ED 2011 | CRITERIA FOR LABORATORY TESTING AND DIAGNOSIS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION |
| CLSI M51 A : 1ED 2010 | METHOD FOR ANTIFUNGAL DISK DIFFUSION SUSCEPTIBILITY TESTING OF NONDERMATOPHYTE FILAMENTOUS FUNGI |
| CLSI EP9 A3 : 3ED 2013 | MEASUREMENT PROCEDURE COMPARISON AND BIAS ESTIMATION USING PATIENT SAMPLES |
| CLSI MM16 A : 1ED 2006 | USE OF EXTERNAL RNA CONTROLS IN GENE EXPRESSION ASSAYS |
| CLSI POCT8 P : 1ED 2009 | QUALITY PRACTICES IN NON-INSTRUMENTED NEAR-PATIENT TESTING: AN INSTRUCTIONAL MANUAL AND RESOURCES FOR HEALTH CARE WORKERS |
| CLSI H2 A5 : 5ED 2011 | PROCEDURES FOR THE ERYTHROCYTE SEDIMENTATION RATE TEST |
| CLSI M53 P : 1ED 2010 | CRITERIA FOR LABORATORY TESTING AND DIAGNOSIS OF HIV INFECTION |
| CLSI M39 A3 : 3ED 2009 | ANALYSIS AND PRESENTATION OF CUMULATIVE ANTIMICROBIAL SUSCEPTIBILITY TEST DATA |
| CLSI VET02 A3 : 3ED 2008 | DEVELOPMENT OF IN VITRO SUSCEPTIBILITY TESTING CRITERIA AND QUALITY CONTROL PARAMETERS FOR VETERINARY ANTIMICROBIAL AGENTS |
| CLSI GP42 A6 : 6ED 2008 | PROCEDURES AND DEVICES FOR THE COLLECTION OF DIAGNOSTIC CAPILLARY BLOOD SPECIMENS |
| CLSI I/LA33 P : 1ED 2009 | VALIDATION OF AUTOMATED DEVICES FOR IMMUNOHEMATOLOGIC TESTING PRIOR TO IMPLEMENTATION |
| CLSI M2 A9 : 9ED 2006 | PERFORMANCE STANDARDS FOR ANTIMICROBIAL DISK SUSCEPTIBILITY TESTS |
| CLSI M24 A2 : 2ED 2011 | SUSCEPTIBILITY TESTING OF MYCOBACTERIA, NOCARDIAE, AND OTHER AEROBIC ACTINOMYCETES |
| CLSI M47 P : 1ED 2006 | PRINCIPLES AND PROCEDURES FOR BLOOD CULTURES |
| CLSI M50 P : 1ED 2008 | QUALITY CONTROL FOR COMMERCIAL MICROBIAL IDENTIFICATION SYSTEMS |
| CLSI GP17 A3 : 3ED 2012 | CLINICAL LABORATORY SAFETY |
| CLSI GP31 A : 1ED 2009 | LABORATORY INSTRUMENT IMPLEMENTATION, VERIFICATION, AND MAINTENANCE |
| CLSI POCT12 A3 : 3ED 2013 | Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities; Approved Guideline—Third Edition<br> |
| CLSI C43 A2 : 2ED 2010 | GAS CHROMATOGRAPHY/MASS SPECTROMETRY CONFIRMATION OF DRUGS |
| CLSI I/LA26 A2 : 2ED 2013 | PERFORMANCE OF SINGLE CELL IMMUNE RESPONSE ASSAYS |
| CLSI C46 A2 : 2ED 2009 | BLOOD GAS AND PH ANALYSIS AND RELATED MEASUREMENTS |
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.